Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Anti-Xa Activity in Elderly Xabans-Treated Patients With Atrial Fibrillation

Samoš, Matej MD, PhD1; Bolek, Tomáš MD1; Škorňová, Ingrid PhD2; Stančiaková, Lucia MD2; Urban, Lukáš MD1; Staško, Ján MD, PhD2; Galajda, Peter MD, PhD1; Kubisz, Peter MD, DSc2; Mokáň, Marián MD, DSc, FRCP Edin1

doi: 10.1097/MJT.0000000000001014
Letters to the Editor: PDF Only
Buy
SDC
PAP

1Department of Internal Medicine I, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic

2Department of Hematology and Blood Transfusion, National Centre of Hemostasis and Thrombosis, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovak Republic

This study was funded by research project APVV (Slovak Research and Development Agency) 16-0020.

The authors have no conflicts of interest to declare.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.americantherapeutics.com).

This research was done according to ethical standards and was approved by the local ethical committee (Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava). The patients agreed to participate in the research and signed informed consent for study participation.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.